Cryoport announced that it has signed a new three-year agreement with Boston IVF, an experienced fertility treatment provider. Utilizing Cryoport’s end-to-end supply chain solutions, Boston IVF will now have the ability to integrate its regional and satellite labs across Massachusetts, New Hampshire, Maine, Rhode Island, New York and Indiana, along with its partner sites in Delaware, Ohio, Idaho, Utah and North Carolina. Cryoport’s platform will improve the overall efficiency of Boston IVF’s reproductive material shipments and ensure significant risk mitigation for patients and families entrusting Boston IVF with their care.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CYRX: